Sanara Medtech Inc is a healthcare company focused on developing and commercializing innovative medical products that enhance the healing process for patients with chronic and complex wounds. The company offers a range of advanced wound care technologies, including biologics, surgical, and non-surgical solutions designed to improve patient outcomes and reduce the burden of healthcare costs. With a commitment to research and development, Sanara aims to address significant medical needs in the wound care market, providing products that empower healthcare professionals in their pursuit of effective treatment strategies. Read More
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its stock experiencing a notable decline. Despite this recent downturn, a significant portion of Wall Street analysts maintain that
Sanara MedTech (SMTI) Q2 2025 earnings show revenue beat estimates with 28% YoY growth, narrowed EPS loss, and 8.4% pre-market surge. Strategic review for Tissue Health Plus underway.
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc (“Sanara”) (Nasdaq:SMTI). In tandem, Sanara agreed to make a minority investment in cash for equity in BMI.
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
